Differentiation of opioid receptor preference by [Dmt1] endomorphin-2-mediated antinociception in the mouse

European Journal of Pharmacology

Volumn 509, Issue 1, 2005, Pages 37-42

  Jinsmaa, Yunden ^a   Fujita, Yoshio ^b   Shiotani, Kimitaka ^b   Miyazaki, Anna ^b   Li, Tingyou ^b   Tsuda, Yuko ^b   Okada, Yoshio ^b   Ambo, Akihiro ^c   Sasaki, Yusuke ^c   Bryant, Sharon D ^a   Lazarus, Lawrence H ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antagonist; Antinociception; Dmt (2 ,6 dimethyl L tyrosine); Endomorphin; Spinal; Supraspinal

Indexed keywords

2',6' DIMETHYLTYROSINE; ANTINOCICEPTIVE AGENT; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ENDOMORPHIN 2; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE DERIVATIVE; OPIATE RECEPTOR; PROTEIN SUBUNIT; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

EID: 13844276195     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.12.015     Document Type: Article

References (37)

1. G. Balboni, S. Salvadori, R. Guerrini, L. Negri, E. Giannini, Y. Jinsmaa, S.D. Bryant, and L.H. Lazarus Potent δ-opioid receptor agonists containing the Dmt-Tic pharmacophore J. Med. Chem. 45 2002 5556 5563
2. R.J. Bodnar, C.L. Williams, S.J. Lee, and G.W. Pasternak Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study Brain Res. 447 1988 25 34
3. S.D. Bryant, S. Salvadori, P.S. Cooper, and L.H. Lazarus New δ-opioid antagonists as pharmacological probes Trends Pharmacol. Sci. 19 1998 42 46
4. S.D. Bryant, Y. Jinsmaa, S. Salvadori, Y. Okada, and L.H. Lazarus Dmt and opioid peptides: a potent alliance Biopolymers (Pept. Sci.) 71 2003 86 102
5. 4 amide bond isostere substitutions J. Med. Chem. 32 1992 2928 2938
6. W.L. Dewey, J.W. Snyder, L.S. Harris, and J.F. Howes The effects of narcotics and narcotic antagonists on the tail-flick response in spinal mice J. Pharm. Pharmacol. 21 1969 548 550
7. Y. Fujita, Y. Tsuda, T. Li, T. Motoyama, M. Takahashi, Y. Shimizu, T. Yokoi, Y. Sasaki, A. Ambo, A. Kita, Y. Jinsmaa, S.D. Bryant, L.H. Lazarus, and Y. Okada Development of potent bifunctional endomorphin-2 analogs with mixed μ/δ-opioid agonist/δ-opioid antagonist properties J. Med. Chem. 47 2004 3591 3599
8. I.E. Goldberg, G.C. Rossi, S.R. Letchworth, J.P. Mathis, J. Ryan-Moro, L. Leventhal, W. Su, D. Emmel, E.A. Bolan, and G.W. Pasternak Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain J. Pharmacol. Exp. Ther. 286 1998 1007 1013
9. 1]deltorphin B Eur. J. Pharmacol. 302 1996 37 42
10. 5]enkephalin J. Med. Chem. 35 1992 684 687
11. J.S. Heyman, C.L. Williams, T.F. Burks, H.I. Mosberg, and F. Porreca Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine J. Pharmacol. Exp. Ther. 245 1988 238 243
12. Y. Jinsmaa, Y. Okada, Y. Tsuda, Y. Sasaki, A. Ambo, S.D. Bryant, and L.H. Lazarus Novel 2′,6′-dimethyl-l-tyrosine-containing pyrazinone opioid mimetic μ agonists with potent antinociceptive activity in mice J. Pharmacol. Exp. Ther. 309 2004 1 7
13. n]-2(1H)-pyrazinone with central mediated analgesia J. Med. Chem. 47 2004 2599 2610
14. S.E. Laursen, and J.K. Belknap Intracerebroventricular injections in mice J. Pharmacol. Methods 16 1986 355 357
15. Li, T., Fujita, Y., Tsuda, Y., Miyazaki, A., Ambo, A., Sasaki, Y., Jinsmaa, Y., Bryant, S.D., Lazarus, L.H., Okada, Y., in press. Development of potent μ-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. J. Med. Chem.
16. G.S. Ling, and G.W. Pasternak Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites Brain Res. 271 1983 152 156
17. Y. Okada, M. Tsukatani, H. Taguchi, T. Yokoi, S.D. Bryant, and L.H. Lazarus Amino acids and peptides. LII. Design and synthesis of opioid mimetics containing a pyrazinone ring and examination of their opioid receptor binding activity Chem. Pharm. Bull. (Tokyo) 46 1998 1374 1382
18. Y. Okada, A. Fukumizu, M. Takahashi, T. Yokoi, Y. Tsuda, S.D. Bryant, and L.H. Lazarus Synthesis of pyrazinone ring-containing opioid mimetics and examination of their opioid receptor binding activity Chem. Pharm. Bull. (Tokyo) 47 1999 1193 1195
19. Y. Okada, Y. Tsuda, Y. Fujita, T. Yokoi, Y. Sasaki, A. Ambo, R. Konishi, M. Nagata, S. Salvadori, Y. Jinsmaa, S.D. Bryant, and L.H. Lazarus Unique high-affinity synthetic μ-opioid receptor agonists with central- and systemic-mediated analgesia J. Med. Chem. 46 2003 3201 3209
20. 1]endomorphin-2 analogues: enhanced activity and cis orientation of Dmt-Pro amide bond Bioorg. Med. Chem. 11 2003 1983 1994
21. G.W. Pasternak, and P.J. Wood Multiple mu opiate receptors Life Sci. 38 1986 1889 1898
22. D. Paul, R.J. Bodnar, M.A. Gistrak, and G.W. Pasternak Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice Eur. J. Pharmacol. 168 1989 307 314
23. B.S. Pitzele, R.W. Hamilton, K.D. Kudla, S. Tsymbalov, A. Stapelfeld, M.A. Savage, M. Clare, D.L. Hammond, and D.W. Hansen Jr. Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide l-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-d-alaninamide J. Med. Chem. 37 1994 888 896
24. F. Porreca, H.I. Mosberg, R. Hurst, V.J. Hruby, and T.F. Burks Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse J. Pharmacol. Exp. Ther. 230 1984 341 348
25. P.S. Portoghese, M. Sultana, and A.E. Takemori Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist Eur. J. Pharmacol. 146 1988 185 186
26. S. Sakurada, J.E. Zadina, A.J. Kastin, S. Katsuyama, T. Fujimura, K. Murayama, M. Yuki, H. Ueda, and T. Sakurada Differential involvement of μ-opioid receptor subtypes in endomorphin-1- and endomorphin-2-induced antinociception Eur. J. Pharmacol. 372 1999 25 30
27. S. Salvadori, M. Attila, G. Balboni, C. Bianchi, S.D. Bryant, O. Crescenzi, R. Guerrini, D. Picone, T. Tancredi, P.A. Temussi, and L.H. Lazarus δ Opioid mimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides Mol. Med. 1 1995 678 689
28. S. Salvadori, G. Balboni, R. Guerrini, R. Tomatis, C. Bianchi, S.D. Bryant, P.S. Cooper, and L.H. Lazarus Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity J. Med. Chem. 40 1997 3100 3108
29. S. Salvadori, R. Guerrini, G. Balboni, C. Bianchi, S.D. Bryant, P.S. Cooper, and L.H. Lazarus Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest μ agonism or μ antagonism J. Med. Chem. 42 1999 5010 5019
30. Y. Sasaki, T. Suto, A. Ambo, H. Ouchi, and Y. Yamamoto Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr Chem. Pharm. Bull. (Tokyo) 47 1999 1506 1509
31. J. Sawynok, C. Pinsky, and F.S. LaBella On the specificity of naloxone as an opiate antagonist Life Sci. 25 1979 1621 1632
32. P.W. Schiller, T.M. Nguyen, I. Berezowska, S. Dupuis, G. Weltrowska, N.N. Chung, and C. Lemieux Synthesis and in vitro opioid activity profiles of DALDA analogues Eur. J. Med. Chem. 35 2000 895 901
33. C. Schmauss, and T.L. Yaksh In vivo studies on spinal opiate receptor systems mediating antinociception: II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat J. Pharmacol. Exp. Ther. 228 1984 1 12
34. L.S. Stone, C.A. Fairbanks, T.M. Laughlin, H.O. Nguyen, T.M. Bushy, M.W. Wessendorf, and G.L. Wilcox Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2 NeuroReport 8 1997 3131 3135
35. A.S. Tung, and T.L. Yaksh In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord Brain Res. 247 1982 75 83
36. B.L. Wolozin, and G.W. Pasternak Classification of multiple morphine and enkephalin binding sites in the central nervous system Proc. Natl. Acad. Sci. U. S. A. 78 1981 6181 6185
37. J.E. Zadina, L. Hackler, L.J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the mu-opiate receptor Nature 386 1997 499 502